KRAS and BRAF mutations and PTEN expression do not predict efficacy of cetuximab-based chemoradiotherapy in locally advanced rectal cancer. (Q54642896)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | KRAS and BRAF mutations and PTEN expression do not predict efficacy of cetuximab-based chemoradiotherapy in locally advanced rectal cancer. |
scientific article |
Statements
KRAS and BRAF mutations and PTEN expression do not predict efficacy of cetuximab-based chemoradiotherapy in locally advanced rectal cancer. (English)
Philipp Erben
Philipp Ströbel
Karoline Horisberger
Juliana Popa
Beatrice Bohn
Benjamin Hanfstein
Georg Kähler
Peter Kienle
Stefan Post
Frederik Wenz
Ralf-Dieter Hofheinz
13 October 2010
81
4
1032-1038